DiagNano is an early stage technology venture focusing on in vitro diagnostics. We will offer nanotechnology-based products for tissue biopsy analysis to provide clinicians with a patient-specific cancer fingerprint. We are currently applying for grants (GRA VentureLab and SBIR) to continue research and development and begin clinical testing.